SL
SLO.F Stella Chemifa Corporation
- Market cap
- EUR 291M
- P/E
- 15.8x
- P/B
- 1.16x
- ROE
- 7.5%
- Dividend yield
- 3.88%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.
Is SLO.F undervalued?
Graham numberSLO.F trades 9.7% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Stella Chemifa Corporation fundamental analysis
No fundamental analysis for Stella Chemifa Corporation yet.
Stella Chemifa Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Stella Chemifa Corporation
Stella Chemifa Corporation manufactures and sells high-purity chemical products in Japan and internationally. It offers hydrofluoric acid, ammonium fluoride, buffered hydrofluoric acid, HG series, and etching solutions used in semiconductors and liquid crystal products; calcium, aluminum, lithium, strontium, barium, magnesium, lead fluoride and fluoride nanoparticles used in optical materials; and lithium hexafluorophosphate and fluoride nanoparticles for batteries. The comp…
Full company profileStella Chemifa Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Stella Chemifa Corporation annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 29.9B | 33.6B | 38.4B | 33.7B | 32.9B | 37.3B | 35.4B | 30.4B | 36.3B | 36.8B | 41.7B |
| Gross Profit | 8.20B | 6.59B | 7.93B | 6.69B | 8.21B | 8.90B | 7.41B | 6.45B | 8.26B | 8.58B | 8.94B |
| Operating Income | 4.37B | 2.38B | 3.54B | 2.42B | 4.08B | 4.58B | 3.51B | 2.72B | 4.34B | 4.65B | 4.74B |
| EBITDA | - | 5.19B | 6.97B | 5.52B | 7.04B | 9.59B | 5.99B | 5.41B | 7.08B | 7.36B | 5.17B |
| Net Income | 2.82B | 1.27B | 2.35B | 1.92B | 2.96B | 5.36B | 2.28B | 1.85B | 2.89B | 3.06B | 3.57B |
| EPS | 230 | 99 | 182 | 149 | 231 | 429 | 190 | 153 | 245 | 251 | 299 |
| Balance Sheet | |||||||||||
| Total Assets | 52.1B | 51.4B | 55.5B | 53.2B | 52.9B | 56.6B | 55.5B | 58.6B | 60.7B | 64.1B | 66.4B |
| Total Liabilities | 22.6B | 18.9B | 21.5B | 18.5B | 16.2B | 13.9B | 12.3B | 14.1B | 15.7B | 16.1B | 18.6B |
| Shareholders' Equity | 28.1B | 31.2B | 32.8B | 34.1B | 36.3B | 42.2B | 42.9B | 44.3B | 44.8B | 47.8B | 47.6B |
| Cash & Short-term Investments | 14.4B | 9.19B | 14.0B | 13.6B | 15.6B | 15.9B | 15.1B | 16.2B | 16.6B | 14.8B | 15.4B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 5.34B | 937M | 7.35B | 5.04B | 7.35B | 5.40B | 5.63B | 6.54B | 7.12B | 6.01B | - |
| Capital Expenditure | 1.54B | 3.34B | 2.99B | 4.55B | 2.39B | 2.70B | 4.59B | 5.86B | 4.17B | 4.59B | 0.00 |
| Free Cash Flow | - | -2.40B | 3.92B | 388M | 4.92B | 2.68B | 1.05B | 683M | 2.95B | 1.42B | - |
| Ratios | |||||||||||
| ROE | 10.1% | 4.1% | 7.2% | 5.6% | 8.2% | 12.7% | 5.3% | 4.2% | 6.5% | 6.4% | 7.5% |
| ROA | 5.4% | 2.5% | 4.2% | 3.6% | 5.6% | 9.5% | 4.1% | 3.1% | 4.8% | 4.8% | 5.4% |
| Net Profit Margin | 9.5% | 3.8% | 6.1% | 5.7% | 9.0% | 14.4% | 6.4% | 6.1% | 8.0% | 8.3% | 8.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Stella Chemifa Corporation dividends
- Dividend yield
- 3.88%
- Forward dividend
- 1.02 EUR
- Payout ratio
- 66.4%
- Ex-dividend date
- Mar 30, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 2.03B | 166 | 66.4% |
| 2025 | JPY 2.18B | 184 | 75.3% |
| 2024 | JPY 1.09B | 91 | 59.2% |
| 2023 | JPY 825M | 69 | 36.2% |
| 2022 | JPY 633M | 51 | 11.8% |
| 2021 | JPY 585M | 46 | 19.8% |
| 2020 | EUR 610M | 47 | 31.7% |
| 2019 | EUR 532M | 41 | 22.6% |
| 2018 | EUR 557M | 43 | 43.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Stella Chemifa Corporation
- Insiders 20.27%
- Institutions 27.93%
- Public & others 51.81%
- Shares outstanding 11.9M
- Free float 7.98M
Stella Chemifa Corporation company profile
- Company name
- Stella Chemifa Corporation
- Ticker
- SLO.F
- ISIN
- JP3399720006
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 683
- Fiscal year end
- March
- Address
- Meiji Yasuda Seimei Osaka Midosuji Bldg, Osaka, Japan, 541-0044
- Phone
- 81 6 4707 1512
- Website
- stella-chemifa.co.jp
About Stella Chemifa Corporation
Stella Chemifa Corporation manufactures and sells high-purity chemical products in Japan and internationally. It offers hydrofluoric acid, ammonium fluoride, buffered hydrofluoric acid, HG series, and etching solutions used in semiconductors and liquid crystal products; calcium, aluminum, lithium, strontium, barium, magnesium, lead fluoride and fluoride nanoparticles used in optical materials; and lithium hexafluorophosphate and fluoride nanoparticles for batteries. The company also provides boron trifluoride, boron trifluoride diethyl ether, boron trifluoride dimethyl ether, boron trifluoride n-butyl ether, boron trifluoride tetrahydrofuran, boron trifluoride phenol, boron trifluoride monoethyl amine, boron trifluoride piperidine, and triethylamine 3HF used in reactive catalysts; and hydrofluoric acid, ammonium fluoride, ammonium hydrogenfluoride, and borofluoride used in surface treatment and alternatives for CFCs. In addition, it offers potassium fluoroborate and boric acid for nuclear energy applications; tin fluoride (II) USP used in GMP-compliant products; and other products, such as potassium fluoride, calcium fluoride, potassium hexafluorozirconate, potassium hexafluorotitanate, sodium fluoride, potassium fluorosilicate, sodium hexafluorosilicate, magnesium hexafluorosilicate, fluoroboric acid, zinc fluoroborate, potassium fluorosilicate, tin fluoroborate, copper fluoroborate, sodium fluoroborate, lead fluoroborate, ammonium hydrogenfluoride, and potassium hexafluorophosphate. Further, the company transportation business, including shipping, custom brokerage, warehousing, and container services. Additionally, it develops Boron Neutron Capture therapy for the treatment of cancer. The company was formerly known as Hashimoto Chemical Corporation and changed its name to Stella Chemifa Corporation in 1997. Stella Chemifa Corporation was founded in 1916 and is headquartered in Osaka, Japan.
Stella Chemifa Corporation management
10- Ms. Aki HashimotoCEO, President & Director · born 1973
- Mr. Yasuhiko NakashimaExecutive Officer of Finance and IR & Director · born 1959
- Mr. Jun TakanoSenior Managing Director of Technology & IR and Head of Research & Development · born 1961
- Mr. Norio OgataHead of Sales Management Department, Executive Officer & Director · born 1968
- Mr. Kiyonori SakaVP & Director · born 1959
- Mr. Masaaki TsuchiyaExecutive Officer of Products Management Group & Director · born 1971
- Mr. Takeshi IijimaExecutive Officer - Singapore Region & Director · born 1966
- Miyuki KoikeExecutive Officer & General Affairs Manager
- Yoshiki NakagawaExecutive Officer & Izumi Factory Manager
- Liu ShibuExecutive Officer